Abbott to acquire Bigfoot Biomedical

Abbott has agreed to acquire Bigfoot Biomedical, a developer of smart insulin management systems. The transaction is expected to close in Q3 2023; financial terms were not disclosed.

“The acquisition of Bigfoot Biomedical will combine two leaders in different aspects of diabetes care: continuous glucose monitoring and insulin dosing support.”abbott.mediaroom.com

• 2 sources
• abbott.mediaroom.comAbbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes - Sep 5, 2023Sep 5, 2023
• massdevice.comFast Five: Abbott to acquire Bigfoot Biomedical, Zimmer Biomet makes handful of executive changes - MassDeviceDanielle KirshSep 7, 2023

Summarized from public sources; check the original articles before acting on it.